180.60SEK+3.20%Mkt Cap: 6.05B SEKP/E: 27.00Last update: 2026-05-13
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology infor…
Industry Peers
Health Information Servicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)27.00
P/E (Forward)26.32
PEG25.65
P/B6.14
P/S4.65
EV/EBITDA17.05
EV/Revenue4.60
EPS (TTM)6.53
EPS (Forward)6.71
Cash Flow & Leverage
FCF Yield1.41%
FCF Margin6.57%
Operating CF387.00M SEK
CapEx (TTM)228.10M SEK
Net Debt/EBITDA-0.18
Net Debt-62.00M SEK
Technical
SMA 50195.80 (-7.8%)
SMA 200219.23 (-17.6%)
Beta0.93
S&P 52W Chg24.23%
Avg Vol (30d)188.87K
Avg Vol (10d)164.27K
Technical Indicators
RSI (14)40.1
MACD-6.0299
MACD Signal-2.3850
MACD Hist.-3.6449
BB Upper244.01 SEK
BB Middle203.10 SEK
BB Lower162.20 SEK
BB Width40.28%
ATR (14)9.436 SEK
Vol Ratio (20d)0.59x
52W Range
166.807% of range373.50
52W High373.50 SEK
52W Low166.80 SEK
Profitability
Gross Margin92.42%
EBITDA Margin26.97%
Profit Margin16.95%
Oper. Margin23.32%
ROE23.12%
ROA11.44%
Revenue Growth-12.30%
Earnings Growth-6.40%
Balance Sheet
Debt/Equity0.40
Current Ratio1.79
Quick Ratio1.71
Book Value/Sh28.74 SEK
Cash/Share12.81 SEK
Dividends
Fwd Div Rate4.000 SEK
Trail. Div Rate4.000 SEK
Div. Yield2.27%
5Y Avg Yield—
Payout Ratio45.87%
Ex-Div DateMay 8, 2026
Pay Date—
Splits
Last Split3:1
Split DateJun 25, 2008
Ownership
Shares Out.30.80M
Float28.10M
Insiders4.81%
Institutions55.80%
Analyst Consensus
Rating—
Target (Mean)330.00 SEK
Target Range290.00 SEK – 370.00 SEK
# Analysts2
Company
Market Cap6.05B SEK
Enterprise Value5.99B SEK
Revenue (TTM)1.30B SEK
Gross Profit1.24B SEK
Net Income (TTM)227.80M SEK
Revenue/Share38.02 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees465
Last Price180.60 SEK
CountrySE
SectorHealthcare
IndustryHealth Information Services
ISINSE0000135485